Ruiz M, Braunstein Z, McLaughlin E, Mishra A, Porcu P, Brammer JE. Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia. Haematologica; https://doi.org/10.3324/haematol.2024.286235 [Early view].